Morbidly obese patients remain an unsolved clinical problem,” explained co-author Gwo-Chin Lee, M.D., a hip and knee replacement surgeon at HSS. “Traditional weight loss measures have had mixed ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

Pfizer abandoned the development of danuglipron and plans to focus its efforts on GIPR candidates and other earlier obesity programs.

So we turned to an expert on the subject to address the top five concerns women have about starting GLP-1 meds like Ozempic. Here, how to outsmart common side effects and hurdles.  Meet our Ozempic ...

Preoperative GLP-1RA use was not significantly associated with an increased risk for postoperative aspiration pneumonia or acute respiratory failure.

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

The following is a summary of “Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and ...

About half of Americans "strongly" or "somewhat" favor having Medicare and Medicaid cover weight-loss drugs for people who ...

In November, Mr. Biden set out to change that with a new rule that would drastically expand access to this type of medication ...